| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |